Hypercoagulability in Cushing's syndrome: The role of specific haemostatic and fibrinolytic markers

Endocrine

Volumn 36, Issue 1, 2009, Pages 70-74

  Kastelan, Darko ^a   Dusek, Tina ^a   Kraljevic, Ivana ^a   Polasek, Ozren ^a,b   Giljevic, Zlatko ^a   Solak, Mirsala ^a   Salek, Silva Zupancic ^a,b,c   Jelcic, Jozo ^a,b   Aganovic, Izet ^a   Korsic, Mirko ^a  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c University Hospital for Lung Diseases Jordanovac   (Croatia)

Author keywords

Coagulation; Cushing's syndrome; Fibrinolysis; Pulmonary embolism; Thrombosis

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR;

ADULT; AGED; ARTICLE; BLOOD; BLOOD CLOTTING TEST; CUSHING SYNDROME; FIBRINOLYSIS; HEMOSTASIS; HUMAN; METABOLISM; MIDDLE AGED; PHYSIOLOGY; THROMBOPHILIA; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CUSHING SYNDROME; FIBRINOLYSIS; HEMOSTASIS; HUMANS; MIDDLE AGED; THROMBOPHILIA; THROMBOSIS; YOUNG ADULT;

EID: 70349578944     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-009-9186-y     Document Type: Article

References (28)

1. J.J. Diez, P. Iglesias, Pulmonary thromboembolism after inferior petrosal sinus sampling in Cushing's syndrome. Clin. Endocrinol. 46, 775-777 (1997)
2. K. Obuobie, J.S. Davies, A. Ogunko, M.F. Scanlon, Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease. J. Endocrinol. Invest. 23, 542-544 (2000)
3. P.L. Semple, E.R. Laws, Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease. J. Neurosurg. 91, 175-179 (1999)
4. A. La Brocca, M. Terzolo, A. Pia, P. Paccotti, P. De Giuli, A. Angeli, Recurrent thromboembolism as a hallmark of Cushing's syndrome. J. Endocrinol. Invest. 20, 211-214 (1997)
5. M. Small, G.D. Lowe, C.D. Forbes, J.A. Thomson, Thromboembolic complications in Cushing's syndrome. Clin. Endocrinol. 19, 503-511 (1983)
6. S. Isacson, Effect of prednisolone on the coagulation and fibrinolytic system. Scand. J. Haematol. 7, 212-221 (1970)
7. A. Oikarinen, M. Hoythya, M. Jarvinen, Dexamethasone-induced plasminogen activator inhibitor: Characterization, purification and preparation of monoclonal anti-bodies. Arch. Dermatol. Res. 282, 153-158 (1990)
8. W.E. Laug, Glucocorticoids inhibit plasminogen activator production by endothelial cells. Thromb. Haemost. 50, 888-892 (1983)
9. P.A. Barouski-Miller, T.D. Gelehrter, Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity of rat hepatoma cells. Proc. Natl. Acad. Sci. USA 79, 2319-2322 (1982)
10. R. Jacoby, J. Owings, T. Ortega, R. Gosselin, E. Feldman, Biochemical basis for the hypercoagulable state seen in Cushing syndrome. Arch. Surg. 136, 1003-1007 (2001)
11. A. Casonato, E. Pontara, M. Boscaro, N. Sonino, F. Sartorello, S. Ferasin, A. Girolami, Abnormalities of von Willebrand factor are also a part of the prothrombotic state of Cushing's syndrome. Blood Coagul. Fibrinolysis 10, 145-151 (1999)
12. H.E. Sjoberg, M. Blomback, P.O. Granberg, Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing's syndrome. Acta Med. Scand. 199, 95-98 (1992)
13. G.M. Patrassi, M.T. Sartori, M.L. Viero, L. Scarano, M. Boscaro, A. Girolami, The fibrinolytic potential in patients with Cushing's disease: A clue to their hypercoagulable state. Blood Coagul Fibrinolysis 3, 789-793 (1992)
14. G.M. Patrassi, R. Dal Bo Zanon, M. Boscaro, S. Martinelli, A. Girolami, Further studies on the hypercoagulable state of patients with Cushing's syndrome. Thromb. Haemost. 54, 518-520 (1985)
15. B. Ambrosi, A. Sartorio, A. Pizzocaro, E. Passini, B. Bottasso, A. Federici, Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma. Exp. Clin. Endocrinol. Diabetes 108, 294-298 (2000)
16. L.M. Fatti, B. Bottasso, C. Invitti, R. Coppola, F. Cavagnini, P.M. Mannucci, Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J. Endocrinol. Invest. 23, 145-150 (2000)
17. M. Boscaro, N. Sonino, A. Scarda, L. Barzon, F. Fallo, M.T. Sartori, G.M. Patrassi, A. Girolami, Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J. Clin. Endocrinol. Metab. 87, 3662-3666 (2002)
18. J. Skrha, Pathogenesis of angiopathy in diabetes. Acta Diabetol. 40, 324-329 (2003)
19. J. Etxabe, J. Vazquez, Morbidity and mortality in Cushing's disease: An epidemiological approach. Clin. Endocrinol. 40, 479-484 (1994)
20. T. Mancini, B. Kola, F. Mantero, M. Boscaro, G. Arnaldi, High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin. Endocrinol. 61, 768-777 (2004)
21. J. Lindholm, S. Juul, J.O.L. Jorgensen, A.P. Bjerre, U. Feldt-Rasmussen, C. Hagen, J. Jorgensen, M. Kosteljanetz, L.O. Kristensen, P. Laurberg, K. Schmidt, J. Weeke, Incidence and late prognosis of Cushing's syndrome: A population-based study. J. Clin. Endocrinol. Metab. 86, 117-123 (2001)
22. M. Prazny, J. Jezkova, E. Horova, V. Lazarova, V. Hana, J. Kvasnicka, L. Pecen, J. Marek, J. Skrha, M. Krsek, Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: Influence of arterial hypertension. Physiol. Res. 57, 13-22 (2008)
23. I. Martens, R.V. Considine, M. Van der Planken, L.F. Van Gaal, Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin? Eur. J. Endocrinol. 155, 477-484 (2006)
24. T. Dusek, D. Kastelan, M. Solak, S. Basic Kinda, I. Aganovic, M. Korsic, Polycythemia as the first manifestation of Cushing's disease. J. Endocrinol. Invest. 31, 940 (2008)
25. M. Reincke, J. Nieke, G.P. Krestin, W. Saeger, B. Allolio, W. Winkelman, Preclinical Cushing's syndrome in adrenal, ,incidentalomas'': Comparison with adrenal Cushing's syndrome. J. Clin. Endocrinol. Metab. 75, 826-832 (1992)
26. M. Terzolo, A. Ali, G. Osella, F. Cesario, P. Paccotti, A. Angeli, Subclinical Cushing's syndrome in adrenal incidentaloma. Clin. Endocrinol. 48, 89-97 (1998)
27. L. Barzon, N. Sonino, N. Fallo, G. Palu, M. Boscaro, Prevalence and natural history of adrenal incidentalomas. Eur. J. Endocrinol. 149, 273-285 (2003)
28. L. Tauchmanova, R. Rossi, B. Biondi, M. Pulcrano, V. Nuzzo, E.A. Palmieri, S. Fazio, G. Lombardi, Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J. Clin. Endocrinol. Metab. 87, 4872-4878 (2002)